---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-000006"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2025-01-02T23:59:59+00:00"
generated_at: "2026-05-28T18:41:03.261472+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab gets Nasdaq extension to May 1, 2025 for bid price compliance; plans reverse split

## Summary
- Nasdaq Hearings Panel grants temporary exception until May 1, 2025 to regain minimum $1.00 bid price.
- Company intends to effect a reverse stock split by April 7, 2025 if needed.
- Effective Jan 30, 2025, Nasdaq requires 10-day prior notice of reverse split details, including shareholder approval date.
- Failure to comply by May 1, 2025 will result in delisting from Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001477932-25-000006
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2025-01-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/0001477932-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-000006
- JSON: https://secwatch.observer/filing/0001477932-25-000006.json
- Plain text: https://secwatch.observer/filing/0001477932-25-000006.txt

## Key facts
- Listing & Compliance Notices
  BioNexus Gene Lab Corp received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: December 27, 2024, BioNexus Gene Lab Corp. (the “Company”) received a written notice from the Nasdaq Hearings Panel (the “Panel”) indicating that the Company has been granted a temporary exception to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the “Bid Price Rule”). The Company has until May 1, 2025, to regain compliance. As part of this compliance plan, the Company intends to effect a reverse stock split, if necessary, no later than April 7, 2025, and has outlined steps to meet this timeline. Failure to regain compliance by May
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737523/000147793225000006/0001477932-25-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.